Utilization of a computerized intravenous insulin infusion program to control blood glucose in the intensive care unit

Rattan Juneja, Corbin Roudebush, Nilay Kumar, Angela Macy, Adam Golas, Donna Wall, Cheryl Wolverton, Deborah Nelson, Joni Carroll, Samuel J. Flanders

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

Background: This proof of concept study was designed to evaluate the safety and effectiveness of an intravenous insulin dosing calculator, the Clarian GlucoStabilizer™ program, and to determine the feasibility of its use as part of a glycemic control program. This paper discusses the impact of the GlucoStabilizer program on the glycemic control of intensive care patients with hyperglycemia. Methods: Patients admitted to the intensive care unit (ICU), requiring intravenous insulin, were treated using the GlucoStabilizer program. This program calculates an insulin drip rate based on the low and high blood glucose (BG) levels of the desired target range, the patient's current and previous BG levels, and an insulin sensitivity factor, with a goal of safely and expeditiously achieving and maintaining the patient's BG in the target range. Results: From October 2004 through March 2006, the GlucoStabilizer program has been used to treat 2,398 patients in the ICUs, with 177,279 BG measurements in its database. In these patients, 61.0% of BGs have been in the target range of 80-110 mg/dL, while 90.9% have been in the wider range of 60-150 mg/dL. The average BG was 106.5 mg/dL (SD 39.1 mg/dL), and the frequency of hypoglycemia (BG <50 mg/dL) was 0.4%. These results compare favorably with the level of glycemic control in the 3 months before implementation of the GlucoStabilizer program. Conclusions: Use of the GlucoStabilizer program in the ICU resulted in improved glycemic control compared to the previous manually calculated glycemic control protocols.

Original languageEnglish
Pages (from-to)232-240
Number of pages9
JournalDiabetes Technology and Therapeutics
Volume9
Issue number3
DOIs
StatePublished - 2007

Fingerprint

Intensive care units
Intravenous Infusions
Intensive Care Units
Blood Glucose
Insulin
Critical Care
Hypoglycemia
Hyperglycemia
Insulin Resistance
Databases
Safety

ASJC Scopus subject areas

  • Endocrinology
  • Medicine (miscellaneous)
  • Clinical Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Utilization of a computerized intravenous insulin infusion program to control blood glucose in the intensive care unit. / Juneja, Rattan; Roudebush, Corbin; Kumar, Nilay; Macy, Angela; Golas, Adam; Wall, Donna; Wolverton, Cheryl; Nelson, Deborah; Carroll, Joni; Flanders, Samuel J.

In: Diabetes Technology and Therapeutics, Vol. 9, No. 3, 2007, p. 232-240.

Research output: Contribution to journalArticle

Juneja, R, Roudebush, C, Kumar, N, Macy, A, Golas, A, Wall, D, Wolverton, C, Nelson, D, Carroll, J & Flanders, SJ 2007, 'Utilization of a computerized intravenous insulin infusion program to control blood glucose in the intensive care unit', Diabetes Technology and Therapeutics, vol. 9, no. 3, pp. 232-240. https://doi.org/10.1089/dia.2006.0015
Juneja, Rattan ; Roudebush, Corbin ; Kumar, Nilay ; Macy, Angela ; Golas, Adam ; Wall, Donna ; Wolverton, Cheryl ; Nelson, Deborah ; Carroll, Joni ; Flanders, Samuel J. / Utilization of a computerized intravenous insulin infusion program to control blood glucose in the intensive care unit. In: Diabetes Technology and Therapeutics. 2007 ; Vol. 9, No. 3. pp. 232-240.
@article{953cc3d428dc4fe48a4d0aad38ed4000,
title = "Utilization of a computerized intravenous insulin infusion program to control blood glucose in the intensive care unit",
abstract = "Background: This proof of concept study was designed to evaluate the safety and effectiveness of an intravenous insulin dosing calculator, the Clarian GlucoStabilizer™ program, and to determine the feasibility of its use as part of a glycemic control program. This paper discusses the impact of the GlucoStabilizer program on the glycemic control of intensive care patients with hyperglycemia. Methods: Patients admitted to the intensive care unit (ICU), requiring intravenous insulin, were treated using the GlucoStabilizer program. This program calculates an insulin drip rate based on the low and high blood glucose (BG) levels of the desired target range, the patient's current and previous BG levels, and an insulin sensitivity factor, with a goal of safely and expeditiously achieving and maintaining the patient's BG in the target range. Results: From October 2004 through March 2006, the GlucoStabilizer program has been used to treat 2,398 patients in the ICUs, with 177,279 BG measurements in its database. In these patients, 61.0{\%} of BGs have been in the target range of 80-110 mg/dL, while 90.9{\%} have been in the wider range of 60-150 mg/dL. The average BG was 106.5 mg/dL (SD 39.1 mg/dL), and the frequency of hypoglycemia (BG <50 mg/dL) was 0.4{\%}. These results compare favorably with the level of glycemic control in the 3 months before implementation of the GlucoStabilizer program. Conclusions: Use of the GlucoStabilizer program in the ICU resulted in improved glycemic control compared to the previous manually calculated glycemic control protocols.",
author = "Rattan Juneja and Corbin Roudebush and Nilay Kumar and Angela Macy and Adam Golas and Donna Wall and Cheryl Wolverton and Deborah Nelson and Joni Carroll and Flanders, {Samuel J.}",
year = "2007",
doi = "10.1089/dia.2006.0015",
language = "English",
volume = "9",
pages = "232--240",
journal = "Diabetes Technology and Therapeutics",
issn = "1520-9156",
publisher = "Mary Ann Liebert Inc.",
number = "3",

}

TY - JOUR

T1 - Utilization of a computerized intravenous insulin infusion program to control blood glucose in the intensive care unit

AU - Juneja, Rattan

AU - Roudebush, Corbin

AU - Kumar, Nilay

AU - Macy, Angela

AU - Golas, Adam

AU - Wall, Donna

AU - Wolverton, Cheryl

AU - Nelson, Deborah

AU - Carroll, Joni

AU - Flanders, Samuel J.

PY - 2007

Y1 - 2007

N2 - Background: This proof of concept study was designed to evaluate the safety and effectiveness of an intravenous insulin dosing calculator, the Clarian GlucoStabilizer™ program, and to determine the feasibility of its use as part of a glycemic control program. This paper discusses the impact of the GlucoStabilizer program on the glycemic control of intensive care patients with hyperglycemia. Methods: Patients admitted to the intensive care unit (ICU), requiring intravenous insulin, were treated using the GlucoStabilizer program. This program calculates an insulin drip rate based on the low and high blood glucose (BG) levels of the desired target range, the patient's current and previous BG levels, and an insulin sensitivity factor, with a goal of safely and expeditiously achieving and maintaining the patient's BG in the target range. Results: From October 2004 through March 2006, the GlucoStabilizer program has been used to treat 2,398 patients in the ICUs, with 177,279 BG measurements in its database. In these patients, 61.0% of BGs have been in the target range of 80-110 mg/dL, while 90.9% have been in the wider range of 60-150 mg/dL. The average BG was 106.5 mg/dL (SD 39.1 mg/dL), and the frequency of hypoglycemia (BG <50 mg/dL) was 0.4%. These results compare favorably with the level of glycemic control in the 3 months before implementation of the GlucoStabilizer program. Conclusions: Use of the GlucoStabilizer program in the ICU resulted in improved glycemic control compared to the previous manually calculated glycemic control protocols.

AB - Background: This proof of concept study was designed to evaluate the safety and effectiveness of an intravenous insulin dosing calculator, the Clarian GlucoStabilizer™ program, and to determine the feasibility of its use as part of a glycemic control program. This paper discusses the impact of the GlucoStabilizer program on the glycemic control of intensive care patients with hyperglycemia. Methods: Patients admitted to the intensive care unit (ICU), requiring intravenous insulin, were treated using the GlucoStabilizer program. This program calculates an insulin drip rate based on the low and high blood glucose (BG) levels of the desired target range, the patient's current and previous BG levels, and an insulin sensitivity factor, with a goal of safely and expeditiously achieving and maintaining the patient's BG in the target range. Results: From October 2004 through March 2006, the GlucoStabilizer program has been used to treat 2,398 patients in the ICUs, with 177,279 BG measurements in its database. In these patients, 61.0% of BGs have been in the target range of 80-110 mg/dL, while 90.9% have been in the wider range of 60-150 mg/dL. The average BG was 106.5 mg/dL (SD 39.1 mg/dL), and the frequency of hypoglycemia (BG <50 mg/dL) was 0.4%. These results compare favorably with the level of glycemic control in the 3 months before implementation of the GlucoStabilizer program. Conclusions: Use of the GlucoStabilizer program in the ICU resulted in improved glycemic control compared to the previous manually calculated glycemic control protocols.

UR - http://www.scopus.com/inward/record.url?scp=34250726549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250726549&partnerID=8YFLogxK

U2 - 10.1089/dia.2006.0015

DO - 10.1089/dia.2006.0015

M3 - Article

C2 - 17561793

AN - SCOPUS:34250726549

VL - 9

SP - 232

EP - 240

JO - Diabetes Technology and Therapeutics

JF - Diabetes Technology and Therapeutics

SN - 1520-9156

IS - 3

ER -